Unfolding of human proinsulin: Intermediates and possible role of its C-peptide in folding/unfolding

European Journal of Biochemistry

Volumn 271, Issue 9, 2004, Pages 1737-1747

  Min, Cheng Yin ^a   Qiao, Zhi Song ^a   Feng, You Min ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

C peptide; Disulfide scrambling; Disulfide stability; Human proinsulin; Unfolding

Indexed keywords

PROINSULIN;

ADDITION REACTION; AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL BOND; CIRCULAR DICHROISM; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FOLDING; REDUCTION; ULTRAVIOLET SPECTROSCOPY;

AMINO ACID SEQUENCE; DISULFIDES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROINSULIN; PROTEIN FOLDING;

SUIDAE;

EID: 2342540452     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.2004.04079.x     Document Type: Article

References (50)

1. Shortle, D. (1996) The denatured state (the other half of the folding equation) and its role in protein stability. FASEB J. 10, 27-34.
2. Rader, A.J., Hespenheide, B.M., Kuhn, L.A. & Thorpe, M.F. (2002) Protein unfolding: rigidity lost. Proc. Natl Acad. Sci. USA 99, 3540-3545.
3. Hespenheide, B.M., Rader, A.J., Thorpe, M.F. & Kuhn, L.A. (2002) Identifying protein folding cores from the evolution of flexible regions during unfolding. J. Mol. Graph. Model. 21, 195-207.
4. Matouschek, A. (2003) Protein unfolding - an important process in vivo? Curr. Opin. Struct. Biol. 13, 98-109.
5. Li, R., Battiste, J.L. & Woodward, C. (2002) Native-like interactions favored in the unfolded bovine pancreatic trypsin inhibitor have different roles in folding. Biochemistry 41, 2246-2253.
6. Radford, S.E., Dobson, C.M. & Evans, P.A. (1992) The folding of hen lysozyme involves partially structured intermediates and multiple pathways. Nature 358, 302-307.
7. Houry, W.A., Rothwarf, D.M. & Scheraga, H.A. (1995) The nature of the initial step in the conformational folding of disulphide-intact ribonuclease A. Nat. Struct. Biol. 2, 495-503.
8. Creighton, T.E. (1984) Disulfide bond formation in proteins. Methods Enzymol. 107, 305-329.
9. Creighton, T.E. (1979) Intermediates in the refolding of reduced ribonuclease A. J. Mol. Biol. 129, 411-431.
10. Li, Y.J., Rothwarf, D.M. & Scheraga, H.A. (1995) Mechanism of reductive protein unfolding. Nat. Struct. Biol. 2, 489-494.
11. Mendoza, J.A., Jarstfer, M.B. & Goldenberg, D.P. (1994) Effects of amino acid replacements on the reductive unfolding kinetics of pancreatic trypsin inhibitor. Biochemistry 33, 1143-1148.
12. Ewbank, J.J. & Creighton, T.E. (1993) Pathway of disulfide-coupled unfolding and refolding of bovine alpha-lactalbumin. Biochemistry 32, 3677-3693.
13. Creighton, T.E. & Goldenberg, D.P. (1984) Kinetic role of a metastable native-like two-disulphide species in the folding transition of bovine pancreatic trypsin inhibitor. J. Mol. Biol. 179, 497-526.
14. Kuwajima, K., Ikeguchi, M., Sugawara, T., Hiraoka, Y. & Sugai, S. (1990) Kinetics of disulfide bond reduction in alpha-lactalbumin by dithiothreitol and molecular basis of superreactivity of the Cys6-Cys120 disulfide bond. Biochemistry 29, 8240-8249.
15. Chang, J.Y. (1997) A two-stage mechanism for the reductive unfolding of disulfide-containing proteins. J. Biol. Chem. 272, 69-75.
16. Chang, J.Y., Li, L., Canals, F. & Aviles, F.X. (2000) The unfolding pathway and conformational stability of potato carboxypeptidase inhibitor. J. Biol. Chem. 275, 14205-14211.
17. Salamanca, S., Villegas, V., Vendrell, J., Li, L., Aviles, F.X. & Chang, J.Y. (2002) The unfolding pathway of leech carboxypeptidase inhibitor. J. Biol. Chem. 277, 17538-17543.
18. Chang, J.Y. & Kumar, T.K.C. (1998) Unfolding and refolding of cardiotoxin III elucidated by reversible conversion of the native and scrambled species. Biochemistry 37, 6745-6751.
19. Steiner, D.F. & Chan, S.J. (1988) An overview of insulin evolution. Horm. Metab. Res. 20, 443-444.
20. Yan, H., Guo, Z.V., Gong, X.W., Xi, D. & Feng, Y.M. (2003) A peptide model of insulin folding intermediate with one disulfide. Protein Sci. 12, 768-775.
21. Weiss, M.A., Hua, Q.X., Jia, W., Chu, Y.C., Wang, R.Y. & Katsoyannis, P.G. (2000) Hierarchical protein 'un-design': insulin's intrachain disulfide bridge tethers a recognition alpha-helix. Biochemistry 39, 15429-15440.
22. Guo, Z.Y. & Feng, Y.M. (2001) Effects of cysteine to serine substitutions in the two inter-chain disulfide bonds of insulin. Biol. Chem. 382, 443-448.
23. Hua, Q.X., Chu, Y.C., Jia, W., Phillips, N.F., Wang, R.Y., Katsoyannis, P.G. & Weiss, M. A. (2002) Mechanism of insulin chain combination. Asymmetric roles of A-chain alpha-helices in disulfide pairing. J. Biol. Chem. 277, 43443-43453.
24. Hua, Q.X., Nakagawa, S.H., Jia, W., Hu, S.Q., Chu, Y.C., Katsoyannis, P.G. & Weiss, M.A. (2001) Hierarchical protein folding: asymmetric unfolding of an insulin analogue lacking the A7-B7 interchain disulfide bridge. Biochemistry 40, 12299-12311.
25. Hua, Q.X., Gozani, S.N., Chance, R.E., Hoffmann, J.A., Frank, B.H. & Weiss, M.A. (1995) Structure of a protein in a kinetic trap. Nat. Struct. Biol. 2, 129-138.
26. Steiner, D.F. (1978) On the role of the proinsulin C-peptide. Diabetes 27 (Suppl. 1), 145-148.
27. Millican, R.L. & Brems, D.N. (1994) Equilibrium intermediates in the denaturation of human insulin and two monomeric insulin analogs. Biochemistry 33, 1116-1124.
28. Bryant, C., Strohl, M., Green, L.K., Long, H.B., Alter, L.A., Pekar, A.H., Chance, R.E. & Brems, D.N. (1992) Detection of an equilibrium intermediate in the folding of a monomeric insulin analog. Biochemistry 31, 5692-5698.
29. Brems, D.N., Brown, P.L., Heckenlaible, L.A. & Frank, B.H. (1990) Equilibrium denaturation of insulin and proinsulin. Biochemistry 29, 9289-9293.
30. Markussen, J. (1971) Structural changes involved in the folding of proinsulin. Int. J. Protein Res. 3, 201-207.
31. Guo, Z.Y., Qiao, Z.S. & Feng, Y.M. (2001) Unfolding of recombinant single-chain insulin in denaturants containing thiol reagents. Sheng Wu Hua Xue. Yu Sheng Wu Wu Li Xue. Bao. (Shanghai) 33, 431-436.
32. Qiao, Z.S., Min, C.Y., Hua, Q.X., Weiss, M.A. & Feng, Y.M. (2003) In vitro refolding of human proinsulin. Kinetic intermediates, putative disulfide-forming pathway folding initiation site, and potential role of C-peptide in folding process. J. Biol. Chem. 278, 17800-17809.
33. Tang, J.G. & Tsou, C.L. (1990) The insulin A and B chains contain structural information for the formation of the native molecule. Studies with protein disulphide-isomerase. Biochem. J. 268, 429-435.
34. Wang, C.C. & Tsou, C.L. (1991) The insulin A and B chains contain sufficient structural information to form the native molecule. Trends Biochem. Sci. 16, 279-281.
35. Qiao, Z.S., Guo, Z.Y. & Feng, Y.M. (2001) Putative disulfide-forming pathway of porcine insulin precursor during its refolding in vitro. Biochemistry 40, 2662-2668.
36. Frank, B.H., Veros, A.J. & Pekar, A.H. (1972) Physical studies on proinsulin. A comparison of the titration behavior of the tyrosine residues in insulin and proinsulin. Biochemistry 11, 4926-4931.
37. Guo, Z.Y., Shen, L. & Feng, Y.M. (2002) The different folding behavior of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain. Biochemistry 41, 1556-1567.
38. Guo, Z.Y., Shen, L. & Feng, Y.M. (2002) The different energetic state of the intra A-chain/domain disulfide of insulin and insulin-like growth factor 1 is mainly controlled by their B-chain/domain. Biochemistry 41, 10585-10592.
39. Guo, Z.Y., Tang, Y.H., Wang, S. & Feng, Y.M. (2003) Contribution of the absolutely conserved B8Gly to the foldability of insulin. Biol. Chem. 384, 805-809.
40. Steiner, D.F. (1973) Cocrystallization of proinsulin and insulin. Nature 243, 528-530.
41. Snell, C.R. & Smyth, D.G. (1975) Proinsulin: a proposed three-dimensional structure. J. Biol. Chem. 250, 6291-6295.
42. Weiss, M.A., Frank, B.H., Khait, I., Pekar, A., Heiney, R., Shoelson, S.E. & Neuringer, L.J. (1990) NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition. Biochemistry 29, 8389-8401.
43. Nagi, A.D. & Regan, L. (1997) An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold. Des. 2, 67-75.
44. Liu, M., Ramos-Castaneda, J. & Arvan, P. (2003) Role of the connecting peptide in insulin biosynthesis. J. Biol. Chem. 278, 14798-14805.
45. Chen, L.M., Yang, X.W. & Tang, J.G. (2002) Acidic residues on the N-terminus of proinsulin C-Peptide are important for the folding of insulin precursor. J. Biochem. (Tokyo) 131, 855-859.
46. Chang, J.Y., Li, L. & Bulychev, A. (2000) The underlying mechanism for the diversity of disulfide folding pathways. J. Biol. Chem. 275, 8287-8289.
47. Chang, J.Y. (1999) Denatured states of tick anticoagulant peptide. Compositional analysis of unfolded scrambled isomers. J. Biol. Chem. 274, 123-128.
48. Chang, J.Y. (1995) The properties of scrambled hirudins. J. Biol. Chem. 270, 25661-25666.
49. Chang, J.Y., Marki, W. & Lai, P.H. (1999) Analysis of the extent of unfolding of denatured insulin-like growth factor. Protein Sci. 8, 1463-1468.
50. Baldwin, R.L. (1989) How does protein folding get started? Trends Biochem. Sci. 14, 291-294.